WebWhile both Jynarque and Samsca contain tolvaptan as the main active ingredient, these two medications are completely different from each other. Jynarque is taken twice a day for a kidney condition called autosomal dominant polycystic kidney disease (ADPKD) and available only through a Risk Evaluation and Mitigation Strategy (REMS) called the … WebMay 5, 2014 · Samsca 15mg/ -30mg Tabletten enthalten den Wirkstoff Tolvaptan. Tolvaptan dient der Behandlung von Erwachsenen mit einer zu niedrigen Natrium-Konzentration im Blut. Dieser Mangel muss durch eine überschießende Produktion des sogenannten antidiuretischen Hormons (ADH, Vasopressin) verursacht sein.
SAMSCA® (tolvaptan) Mechanism of Action
WebDer Wirkstoff ist Tolvaptan. Jede Samsca 7,5 mg Tablette enthält 7,5 mg Tolvaptan. Jede Samsca 15 mg Tablette enthält 15 mg Tolvaptan. Jede Samsca 30 mg Tablette enthält 30 mg Tolvaptan. Die sonstigen Bestandteile sind: Lactose-Monohydrat, Maisstärke, mikrokristalline Cellulose, Hyprolose, Magnesiumstearat, Indigocarmin-Aluminiumsalz (E … WebMay 30, 2024 · Official answer. Jynarque and Samsca both contain tolvaptan. Jynarque is used to slow kidney function decline in adults at risk of developing polycystic kidney disease. Samsca is used to help increase sodium levels in patients with heart failure, and some hormone imbalances. Jynarque, from Otsuka Pharmaceuticals, is used to slow … the spirit dc
Samsca European Medicines Agency
WebJul 1, 2024 · Samsca is a medicine for treating abnormally low levels of sodium in the blood in adults with a condition called ‘syndrome of inappropriate antidiuretic hormone … WebFeb 23, 2024 · Samsca must not be taken with grapefruit juice (see section 4.5). Special populations. Renal impairment. Tolvaptan is contraindicated in anuric patients (see section 4.3). Tolvaptan has not been studied in patients with severe renal failure. The efficacy and safety in this population is not well established. WebTolvaptan. Tolvaptan, sold under the brand name Samsca among others, is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 (V 2) antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). mysql is not exist